Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 751068, 10 pages
http://dx.doi.org/10.1155/2013/751068
Review Article

Probiotics in the Management of Lung Diseases

1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands
2Chronic Respiratory Diseases Research Center and National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Department of Immunology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK
4Danone Research Centre for Specialised Nutrition, Wageningen, The Netherlands

Received 1 December 2012; Revised 14 March 2013; Accepted 28 March 2013

Academic Editor: Alex Kleinjan

Copyright © 2013 Esmaeil Mortaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Borody, E. F. Warren, S. M. Leis, R. Surace, O. Ashman, and S. Siarakas, “Bacteriotherapy using fecal flora: toying with human motions,” Journal of Clinical Gastroenterology, vol. 38, no. 6, pp. 475–483, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. L. D'Souza, C. Rajkumar, J. Cooke, and C. J. Bulpitt, “Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis,” British Medical Journal, vol. 324, no. 7350, pp. 1361–1364, 2002. View at Google Scholar · View at Scopus
  3. S. Salminen, C. Gibson, M. C. Bouley et al., “Gastrointestinal physiology and function: the role of prebiotics and probiotics,” British Journal of Nutrition, vol. 80, supplement 1, pp. 147–171, 1998. View at Google Scholar
  4. F. Guarner, A. Khan, J. Garisch et al., World Gastroenterology Organisation Practice Guideline: Probiotics and Prebiotics, WGO, Munich, Germany, 2008.
  5. C. Rousseaux, X. Thuru, A. Gelot et al., “Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors,” Nature Medicine, vol. 13, no. 1, pp. 35–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. F. Verdú, P. Bercik, M. Verma-Gandhu et al., “Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice,” Gut, vol. 55, no. 2, pp. 182–194, 2006. View at Google Scholar · View at Scopus
  7. M. B. Roberfroid, “Prebiotics and synbiotics: concepts and nutritional properties. Université Catholique de Louvain, Department of Pharmaceutical Sciences, Brussels, Belgium,” British Journal of Nutrition, vol. 80, supplement 4, pp. S197–S202, 1998. View at Google Scholar
  8. T. Kamiya, L. Wang, P. Forsythe et al., “Inhibitory effects of Lactobocillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats,” Gut, vol. 55, no. 2, pp. 191–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. F. Verdú, P. Bercík, G. E. Bergonzelli et al., “Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction,” Gastroenterology, vol. 127, no. 3, pp. 826–837, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Oelschlaeger, “Mechanisms of probiotic actions—a review,” International Journal of Medical Microbiology, vol. 300, no. 1, pp. 57–62, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Morimoto, T. Takeshita, M. Nanno, S. Tokudome, and K. Nakayama, “Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers,” Preventive Medicine, vol. 40, no. 5, pp. 589–594, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. V. Rao, A. C. Bested, T. M. Beaulne et al., “A randomized, double blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome,” Gut Pathology, vol. 19, pp. 1–6, 2009. View at Google Scholar
  13. S. C. Ng, A. L. Hart, M. A. Kamm, A. J. Stagg, and S. C. Knight, “Mechanisms of action of probiotics: recent advances,” Inflammatory Bowel Diseases, vol. 15, no. 2, pp. 300–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Hörmannsperger and D. Haller, “Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease,” International Journal of Medical Microbiology, vol. 300, no. 1, pp. 63–73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. So, C. G. Lee, H. K. Kwon et al., “Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis,” Molecular Immunology, vol. 46, no. 1, pp. 172–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Ghadimi, R. Fölster-Holst, M. de Vrese, P. Winkler, K. J. Heller, and J. Schrezenmeir, “Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects,” Immunobiology, vol. 213, no. 8, pp. 677–692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. K. Kwon, C. G. Lee, J. S. So et al., “Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 2159–2164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. L. Cross, L. M. Stevenson, and H. S. Gill, “Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria?” International Immunopharmacology, vol. 1, no. 5, pp. 891–901, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. C. B. M. Maassen, C. van Holten-Neelen, F. Balk et al., “Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains,” Vaccine, vol. 18, no. 23, pp. 2613–2623, 2000. View at Google Scholar · View at Scopus
  20. K. Takeda, T. Suzuki, S. I. Shimada, K. Shida, M. Nanno, and K. Okumura, “Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota,” Clinical and Experimental Immunology, vol. 146, no. 1, pp. 109–115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Isolauri, S. Salminen, and A. C. Ouwehand, “Probiotics,” Best Practice and Research: Clinical Gastroenterology, vol. 18, no. 2, pp. 299–313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. Noverr and G. B. Huffnagle, “The “microflora hypothesis” of allergic diseases,” Clinical and Experimental Allergy, vol. 35, no. 12, pp. 1511–1520, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Sudo, X. N. Yu, Y. Aiba et al., “An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice,” Clinical and Experimental Allergy, vol. 32, no. 7, pp. 1112–1116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. M. I. Alvarez-Olmos and R. A. Oberhelman, “Probiotic agents and infectious diseases: a mode rn pe rspe c tive on a tr aditional the rapy,” Clinical Infectious Diseases, vol. 32, pp. 1567–1576, 2001. View at Google Scholar
  25. J. A. Vanderhoof and R. Young, “Probiotics in the United States,” Clinical Infectious Diseases, vol. 46, supplement 2, pp. S67–S72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. I. G. Bogdanov, V. T. Velichkov, and A. I. Gurevich, “Antitumor effect of glycopeptides from the cell wall of Lactobacillus bulgaricus,” Byulleten Eksperimentalnoi Biologii i Meditsiny, vol. 84, no. 12, pp. 709–712, 1977. View at Google Scholar · View at Scopus
  27. G. Hepner, R. Fried, S. St Jeor, L. Fusetti, and R. Morin, “Hypocholesterolemic effect of yogurt and milk,” The American Journal of Clinical Nutrition, vol. 32, pp. 19–24, 1979. View at Google Scholar
  28. B. Batdorj, V. Trinetta, M. Dalgalarrondo et al., “Isolation, taxonomic identification and hydrogen peroxide production by Lactobacillus delbrueckii subsp. lactis T31, isolated from Mongolian yoghurt: inhibitory activity on food-borne pathogens,” Journal of Applied Microbiology, vol. 103, no. 3, pp. 584–593, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. I. A. Abd El-Gawad, E. M. El-Sayed, S. A. Hafez, H. M. El-Zeini, and F. A. Saleh, “Inhibitory effect of yoghurt and soya yoghurt containing bifidobacteria on the proliferation of Ehrlich ascites tumour cells in vitro and in vivo in a mouse tumour model,” British Journal of Nutrition, vol. 92, no. 1, pp. 81–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Takahashi, T. Oka, H. Iwana, T. Kuwata, and Y. Yamamoto, “Immune response of mice to orally administered lactic acid bacteria,” Bioscience, Biotechnology, and Biochemistry, vol. 57, pp. 1557–1560, 1993. View at Google Scholar
  31. Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. Guidelines for the evaluation of probiotics in food, 2002, ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
  32. O. N. Donkor, M. Ravikumar, O. Proudfoot et al., “Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure,” Clinical & Experimental Immunology, vol. 167, pp. 282–295, 2012. View at Google Scholar
  33. M. Girardin and E. G. Seidman, “Indications for the use of probiotics in gastrointestinal diseases,” Digestive Diseases, vol. 29, pp. 574–587, 2011. View at Google Scholar
  34. M. C. Noverr and G. B. Huffnagle, “The “microflora hypothesis” of allergic diseases,” Clinical and Experimental Allergy, vol. 35, no. 12, pp. 1511–1520, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. L. Cross, A. Ganner, D. Teilab, and L. M. Fray, “Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria,” FEMS Immunology and Medical Microbiology, vol. 42, no. 2, pp. 173–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Ghadimi, R. Fölster-Holst, M. de Vrese, P. Winkler, K. J. Heller, and J. Schrezenmeir, “Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects,” Immunobiology, vol. 213, no. 8, pp. 677–692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. U. Helwig, K. M. Lammers, F. Rizzello et al., “Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells,” World Journal of Gastroenterology, vol. 12, no. 37, pp. 5978–5986, 2006. View at Google Scholar · View at Scopus
  38. A. Hosono, T. Kashina, and T. Kada, “Antimutagenic properties of lactic acid-cultured milk on chemical and fecal mutagens,” Journal of Dairy Science, vol. 69, no. 9, pp. 2237–2242, 1986. View at Google Scholar · View at Scopus
  39. A. Pillai and R. Nelson, “Probiotics for treatment of Clostridium difficile-associated colitis in adults,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD004611, 2008. View at Google Scholar · View at Scopus
  40. S. J. Allen, B. Okoko, E. Martinez, G. Gregorio, and L. F. Dans, “Probiotics for treating infectious diarrhoea,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD003048, 2004. View at Google Scholar · View at Scopus
  41. M. Hickson, “Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial,” British Medical Journal, vol. 335, article 80, 2007. View at Google Scholar
  42. G. Harata, F. He, M. Kawase, A. Hosono, K. Takahashi, and S. Kaminogawa, “Differentiated implication of Lactobacillus GG and L. gasseri TMC0356 to immune responses of murine Peyer's patch,” Microbiology and Immunology, vol. 53, no. 8, pp. 475–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Izumo, T. Maekawa, M. Ida et al., “Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice,” International Immunopharmacology, vol. 10, no. 9, pp. 1101–1106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Harata, F. He, N. Hiruta et al., “Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses,” Letters in Applied Microbiology, vol. 50, no. 6, pp. 597–602, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Koizumi, D. Wakita, T. Sato et al., “Essential role of Toll-like receptors for dendritic cell and NK1. 1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84,” Immunology Letters, vol. 120, pp. 14–19, 2008. View at Google Scholar
  46. T. S. Plantinga, W. W. van Maren, J. van Bergenhenegouwen et al., “Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics,” Clinical and Vaccine Immunology, vol. 18, pp. 621–628, 2011. View at Google Scholar
  47. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Lin, N. Truong, W. J. Grossman et al., “Allergic dysregulation and hyperimmunoglobulinemia e in Foxp3 mutant mice,” Journal of Allergy and Clinical Immunology, vol. 116, no. 5, pp. 1106–1115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. C. L. Bennett, J. Christie, F. Ramsdell et al., “The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3,” Nature Genetics, vol. 27, no. 1, pp. 20–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Karimi, M. D. Inman, J. Bienenstock, and P. Forsythe, “Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 3, pp. 186–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. W. Feleszko, J. Jaworska, R. D. Rha et al., “Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma,” Clinical and Experimental Allergy, vol. 37, no. 4, pp. 498–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Kalliomäki, S. Salminen, T. Poussa, and E. Isolauri, “Probiotics during the first 7 years of life: cumulative risk reduction of eczema in a randomized, placebo-controlled trial,” Journal of Allergy and Clinical Immunology, vol. 119, no. 4, pp. 1019–1021, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Baharav, F. Mor, M. Halpern, and A. Weinberger, “Lactobacillus GG bacteria ameliorate arthritis in Lewis rats,” Journal of Nutrition, vol. 134, no. 8, pp. 1964–1969, 2004. View at Google Scholar · View at Scopus
  55. S. Salva, J. Villena, and S. Alvarez, “Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections,” International Journal of Food Microbiology, vol. 141, no. 1-2, pp. 82–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Alvarez, C. Herrero, E. Bru, and G. Perdigon, “Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice,” Journal of Food Protection, vol. 64, no. 11, pp. 1768–1774, 2001. View at Google Scholar
  57. T. Hori, J. Kivoshima, K. Shida, and H. Yasui, “Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota,” Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 1, pp. 105–108, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Hougee, A. J. M. Vriesema, S. C. Wijering et al., “Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study,” International Archives of Allergy and Immunology, vol. 151, no. 2, pp. 107–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. J. K. Peat, R. H. van den Berg, W. F. Green, C. M. Mellis, S. R. Leeder, and A. J. Woolcock, “Changing prevalence of asthma in Australian children,” British Medical Journal, vol. 308, no. 6944, pp. 1591–1596, 1994. View at Google Scholar · View at Scopus
  60. M. I. Asher, S. Montefort, B. Björkstén et al., “Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: iSAAC phases one and three repeat multicountry cross-sectional surveys,” The Lancet, vol. 368, no. 9537, pp. 733–743, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. R. C. Leung, J. B. Carlin, J. G. W. Burdon, and D. Czarny, “Asthma, allergy and atopy in Asian immigrants in Melbourne,” Medical Journal of Australia, vol. 161, no. 7, pp. 418–425, 1994. View at Google Scholar · View at Scopus
  62. S. H. Sicherer, R. A. Wood, D. Stablein et al., “Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants,” Journal of Allergy and Clinical Immunology, vol. 126, no. 6, pp. 1191–1197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Kalliomäki, S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri, “Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial,” The Lancet, vol. 357, no. 9262, pp. 1076–1079, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Rautava, M. Kalliomäki, and E. Isolauri, “Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant,” Journal of Allergy and Clinical Immunology, vol. 109, no. 1, pp. 119–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Kalliomäki, S. Salminen, T. Poussa, H. Arvilommi, and E. Isolauri, “Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial,” The Lancet, vol. 361, no. 9372, pp. 1869–1871, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Isolauri, T. Arvola, Y. Sutas, E. Moilanen, and S. Salminen, “Probiotics in the management of atopic eczema,” Clinical and Experimental Allergy, vol. 30, no. 11, pp. 1604–1610, 2000. View at Google Scholar · View at Scopus
  67. H. Majamaa and E. Isolauri, “Probiotics: a novel approach in the management of food allergy,” Journal of Allergy and Clinical Immunology, vol. 99, no. 2, pp. 179–185, 1997. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Kalliomäki, S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri, “Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial,” The Lancet, vol. 357, no. 9262, pp. 1076–1079, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Weston, A. Halbert, P. Richmond, and S. L. Prescott, “Effects of probiotics on atopic dermatitis: a randomised controlled trial,” Archives of Disease in Childhood, vol. 90, no. 9, pp. 892–897, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. M. L. Brouwer, S. A. A. Wolt-Plompen, A. E. J. Dubios et al., “No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial,” Clinical and Experimental Allergy, vol. 36, no. 7, pp. 899–906, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. A. L. Taylor, J. A. Dunstan, and S. L. Prescott, “Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial,” Journal of Allergy and Clinical Immunology, vol. 119, no. 1, pp. 184–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. M. V. Kopp, I. Hennemuth, A. Heinzmann, and R. Urbanek, “Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of lactobacillus gg supplementation,” Pediatrics, vol. 121, no. 4, pp. e850–e856, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. C. E. West, M. L. Hammarström, and O. Hernell, “Probiotics during weaning reduce the incidence of eczema,” Pediatric Allergy and Immunology, vol. 20, no. 5, pp. 430–437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. E. Isolauri, T. Arvola, Y. Sutas, E. Moilanen, and S. Salminen, “Probiotics in the management of atopic eczema,” Clinical and Experimental Allergy, vol. 30, no. 11, pp. 1604–1610, 2000. View at Google Scholar · View at Scopus
  75. O. Ozdemir, “Any benefits of probiotics in allergic disorders?” Allergy and Asthma Proceedings, vol. 31, no. 2, pp. 103–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Forsythe, M. D. Inman, and J. Bienenstock, “Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 6, pp. 561–569, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Kalliomäki and E. Isolauri, “Role of intestinal flora in the development of allergy,” Current Opinion in Allergy and Clinical Immunology, vol. 3, no. 1, pp. 15–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Fuller, “Probiotics in man and animals,” Journal of Applied Bacteriology, vol. 66, no. 5, pp. 365–378, 1989. View at Google Scholar · View at Scopus
  79. W. Feleszko, J. Jaworska, R. D. Rha et al., “Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma,” Clinical and Experimental Allergy, vol. 37, no. 4, pp. 498–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. M. A. Rose, F. Stieglitz, A. Köksal, R. Schubert, J. Schulze, and S. Zielen, “Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk,” Clinical and Experimental Allergy, vol. 40, no. 9, pp. 1398–1405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. J. A. Wisniewski and X. M. Li, “Alternative and complementary treatment for food allergy,” Immunology and Allergy Clinics of North America, vol. 32, pp. 135–150, 2012. View at Google Scholar
  82. H. H. Smits, A. Engering, D. van der Kleij et al., “Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin,” Journal of Allergy and Clinical Immunology, vol. 115, no. 6, pp. 1260–1267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Zuany-Amorim, E. Sawicka, C. Manlius et al., “Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells,” Nature Medicine, vol. 8, no. 6, pp. 625–629, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. W. Feleszko, J. Jaworska, R. D. Rha et al., “Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma,” Clinical and Experimental Allergy, vol. 37, no. 4, pp. 498–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. C. O'Mahony, P. Scully, D. O'Mahony et al., “Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-κB activation,” PLoS Pathogens, vol. 4, no. 8, Article ID e1000112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. B. Zhang, J. An, T. Shimada, S. Liu, and K. Maeyama, “Oral administration of Enterococcus faecalis FK-23 suppresses Th17 cell development and attenuates allergic airway responses in mice,” International Journal of Molecular Medicine, vol. 24, no. 2, pp. 248–254, 2012. View at Publisher · View at Google Scholar
  87. M. J. Holtzman, D. E. Byers, L. A. Benoit et al., “Chapter 5 immune pathways for translating viral infection into chronic airway disease1,” Advances in Immunology, vol. 102, pp. 245–276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Yoo, H. Tcheurekdjian, S. V. Lynch, M. Cabana, and H. A. Boushey, “Microbial manipulation of immune function for asthma prevention inferences from clinical trials,” Proceedings of the American Thoracic Society, vol. 4, no. 3, pp. 277–282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Saxelin, S. Salminen, and E. Isolauri, “Clinical efficacy of a human Lactobacillus strain as a probiotic,” in Functional Foods: The Consumer, the Products and the Evidence, M. J. Sadler and M. Saltmarsh, Eds., Royal Society of Chemistry, Cambridge, UK, 1998. View at Google Scholar
  90. H. Yasui, J. Kiyoshima, T. Hori, and K. Shida, “Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064,” Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 2, pp. 186–192, 1999. View at Google Scholar · View at Scopus
  91. H. Yasui, J. Kiyoshima, and T. Hori, “Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 4, pp. 675–679, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. T. Hori, J. Kiyoshima, K. Shida, and H. Yasui, “Effect of intranasal administration of Lactobacillus casei shirota on influenza virus infection of upper respiratory tract in mice,” Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 3, pp. 593–597, 2001. View at Publisher · View at Google Scholar · View at Scopus
  93. B. R. Goldin and S. L. Gorbach, “Clinical indications for probiotics: an overview,” Clinical Infectious Diseases, vol. 46, supplement 2, pp. S96–S100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. G. Harata, F. He, N. Hiruta et al., “Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses,” Letters in Applied Microbiology, vol. 50, no. 6, pp. 597–602, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. L. E. Morrow, M. H. Kollef, and T. B. Casale, “Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 8, pp. 1058–1064, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Hatakka, E. Savilahti, A. Pönkä et al., “Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial,” British Medical Journal, vol. 322, no. 7298, pp. 1327–1329, 2001. View at Google Scholar · View at Scopus
  97. I. Hojsak, S. Abdović, H. Szajewska, M. Milošević, Z. Krznarić, and S. Kolaček, “Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections,” Pediatrics, vol. 125, no. 5, pp. e1171–e1177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. M. de Vrese, P. Winkler, P. Rautenberg et al., “Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial,” Vaccine, vol. 24, no. 44–46, pp. 6670–6674, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. K. F. Rabe, S. Hurd, A. Anzueto et al., “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 6, pp. 532–555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. P. J. Barnes, “Neutrophils find smoke attractive,” Science, vol. 330, no. 6000, pp. 40–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. I. M. Adcock, G. Caramori, and P. J. Barnes, “Chronic obstructive pulmonary disease and lung cancer: new molecular insights,” Respiration, vol. 81, no. 4, pp. 265–268, 2011. View at Google Scholar · View at Scopus
  102. N. E. Tzanakis, I. G. Tsiligianni, and N. M. Siafakas, “Pulmonary involvement and allergic disorders in inflammatory bowel disease,” World Journal of Gastroenterology, vol. 16, no. 3, pp. 299–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. B. Basseri, P. Enayati, A. Marchevsky, and K. A. Papadakis, “Pulmonary manifestations of inflammatory bowel disease: case presentations and review,” Journal of Crohn's and Colitis, vol. 4, no. 4, pp. 390–397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. H. Black, M. Mendoza, and S. Murin, “Thoracic manifestations of inflammatory bowel disease,” Chest, vol. 131, no. 2, pp. 524–532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. T. A. Fedorova, L. I. Spirina, N. E. Chernekhovskaia et al., “The stomach and duodenum condition in patients with chronic obstructive lung diseases,” Klinicheskaia meditsina, vol. 81, no. 10, pp. 31–33, 2003. View at Google Scholar · View at Scopus
  106. A. Benard, P. Desreumeaux, D. Huglo, A. Hoorelbeke, A. B. Tonnel, and B. Wallaert, “Increased intestinal permeability in bronchial asthma,” Journal of Allergy and Clinical Immunology, vol. 97, no. 6, pp. 1173–1178, 1996. View at Publisher · View at Google Scholar · View at Scopus
  107. J. B. Levine and D. Lukawski-Trubish, “Extraintestinal considerations in inflammatory bowel disease,” Gastroenterology Clinics of North America, vol. 24, no. 3, pp. 633–646, 1995. View at Google Scholar · View at Scopus
  108. S. Keely, N. J. Talley, and P. M. Hansbro, “Pulmonary-intestinal cross-talk in mucosal inflammatory disease,” Mucosal Immunology, vol. 5, pp. 7–18, 2012. View at Google Scholar
  109. S. I. Rennard and J. Vestbo, “COPD: the dangerous underestimate of 15%,” The Lancet, vol. 367, no. 9518, pp. 1216–1219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. M. G. Cosio, M. Saetta, and A. Agusti, “Immunologic aspects of chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 360, no. 23, pp. 2396–2454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. J. C. Hogg, F. Chu, S. Utokaparch et al., “The nature of small-airway obstruction in chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 350, no. 26, pp. 2645–2653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  112. M. G. Cosio, M. Saetta, and A. Agusti, “Immunologic aspects of chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 360, no. 23, pp. 2396–2454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. M. T. Borchers, S. C. Wesselkamper, V. Curull et al., “Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease,” The Journal of Clinical Investigation, vol. 119, no. 3, pp. 636–649, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. G. T. Motz, B. L. Eppert, G. Sun et al., “Persistence of lung CD8 T cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke-induced emphysema,” Journal of Immunology, vol. 181, no. 11, pp. 8036–8043, 2008. View at Google Scholar · View at Scopus
  115. M. T. Borchers, S. C. Wesselkamper, N. L. Harris et al., “CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposure,” Experimental and Molecular Pathology, vol. 83, no. 3, pp. 301–310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. E. Sapey and R. A. Stockley, “COPD exacerbations · 2: aetiology,” Thorax, vol. 61, no. 3, pp. 250–258, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. A. Bhowmik, T. A. R. Seemungal, R. J. Sapsford, and J. A. Wedzicha, “Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations,” Thorax, vol. 55, no. 2, pp. 114–120, 2000. View at Publisher · View at Google Scholar · View at Scopus
  118. J. K. Quint, R. Baghai-Ravary, G. C. Donaldson, and J. A. Wedzicha, “Relationship between depression and exacerbations in COPD,” European Respiratory Journal, vol. 32, no. 1, pp. 53–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. E. Sapey and R. A. Stockley, “COPD exacerbations · 2: aetiology,” Thorax, vol. 61, no. 3, pp. 250–258, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. B. R. Celli and P. J. Barnes, “Exacerbations of chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 29, no. 6, pp. 1224–1238, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. M. J. Kang, G. L. Chun, J. Y. Lee et al., “Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice,” The Journal of Clinical Investigation, vol. 118, no. 8, pp. 2771–2778, 2008. View at Google Scholar · View at Scopus
  122. K. C. Newman and E. M. Riley, “Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens,” Nature Reviews Immunology, vol. 7, no. 4, pp. 279–291, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. T. Kawai and S. Akira, “Innate immune recognition of viral infection,” Nature Immunology, vol. 7, no. 2, pp. 131–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. K. C. Newman and E. M. Riley, “Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens,” Nature Reviews Immunology, vol. 7, no. 4, pp. 279–291, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. T. Kawai and S. Akira, “Innate immune recognition of viral infection,” Nature Immunology, vol. 7, no. 2, pp. 131–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. M. Lucas, W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach, “Dendritic cells prime natural killer cells by trans-presenting interleukin 15,” Immunity, vol. 26, no. 4, pp. 503–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. T. Strowig, F. Brilot, and C. Münz, “Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity,” Journal of Immunology, vol. 180, no. 12, pp. 7785–7791, 2008. View at Google Scholar · View at Scopus
  128. J. R. Ortaldo, R. T. Winkler-Pickett, H. Yagita, and H. A. Young, “Comparative studies of CD3 and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression,” Cellular Immunology, vol. 136, no. 2, pp. 486–495, 1991. View at Publisher · View at Google Scholar · View at Scopus
  129. T. Strowig, F. Brilot, and C. Münz, “Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity,” Journal of Immunology, vol. 180, no. 12, pp. 7785–7791, 2008. View at Google Scholar · View at Scopus
  130. K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume, “Interferon-γ: an overview of signals, mechanisms and functions,” Journal of Leukocyte Biology, vol. 75, no. 2, pp. 163–189, 2004. View at Publisher · View at Google Scholar · View at Scopus
  131. T. Strowig, F. Brilot, and C. Münz, “Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity,” Journal of Immunology, vol. 180, no. 12, pp. 7785–7791, 2008. View at Google Scholar · View at Scopus
  132. J. S. Orange, B. Wang, C. Terhorst, and C. A. Biron, “Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration,” Journal of Experimental Medicine, vol. 182, no. 4, pp. 1045–1056, 1995. View at Publisher · View at Google Scholar · View at Scopus
  133. T. M. Scharton and P. Scott, “Natural killer cells are a source of interferon γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice,” Journal of Experimental Medicine, vol. 178, no. 2, pp. 567–577, 1993. View at Google Scholar · View at Scopus
  134. M. F. Mian, N. M. Lauzon, M. R. Stämpfli, K. L. Mossman, and A. A. Ashkar, “Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke,” Journal of Leukocyte Biology, vol. 83, no. 3, pp. 774–784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Naruszewicz, M. L. Johansson, D. Zapolska-Downar, and H. Bukowska, “Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers,” American Journal of Clinical Nutrition, vol. 76, no. 6, pp. 1249–1255, 2002. View at Google Scholar · View at Scopus
  136. T. Chinen and A. Y. Rudensky, “The effects of commensal microbiota on immune cell subsets and inflammatory responses,” Immunological Reviews, vol. 245, pp. 45–55, 2012. View at Google Scholar
  137. A. V. Chervonsky, “Microbial influences on immune function and more,” Immunological Reviews, vol. 245, pp. 7–12, 2012. View at Google Scholar